Signify Health (Signify Health) 3-Year EBITDA Growth Rate : 0.00% (As of Dec. 2022)

View and export this data going back to 2021. Start your Free Trial

What is Signify Health 3-Year EBITDA Growth Rate?

Signify Health's EBITDA per Share for the three months ended in Dec. 2022 was $3.65.

During the past 12 months, Signify Health's average EBITDA Per Share Growth Rate was -150.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 5 years, the highest 3-Year average EBITDA Per Share Growth Rate of Signify Health was 43.40% per year. The lowest was 43.40% per year. And the median was 43.40% per year.

Competitive Comparison of Signify Health's 3-Year EBITDA Growth Rate

For the Health Information Services subindustry, Signify Health's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Signify Health's 3-Year EBITDA Growth Rate Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Signify Health's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Signify Health's 3-Year EBITDA Growth Rate falls into.

Signify Health 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Signify Health (NYSE:SGFY) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Signify Health 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Signify Health's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Signify Health (Signify Health) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Signify Health Inc (NYSE:SGFY) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

800 Connecticut Avenue, 3rd Floor, Norwalk, CT, USA, 06854

Website

http://www.signifyhealth.com

Signify Health Inc is a healthcare technology company that leverages advanced analytics, technology, and nationwide healthcare provider networks to create and power value-based payment programs. The customers include health plans, governments, employers, health systems and physician groups. Its operating segment includes Home and Community Services and Episodes of Care Services. The company generates maximum revenue from the Home and Community Services segment.

Executives

David Pierre	officer: Chief Operating Officer	800 CONNECTICUT AVENUE, NORWALK CT 06854
Paymon Farazi	officer: Chief Product Officer	C/O SIGNIFY HEALTH, INC., 800 CONNECTICUT AVE, NORWALK CT 06854
Tim Gronniger	officer: Ch. Value-Based Sols. Off	C/O SIGNIFY HEALTH, INC., 800 CONNECTICUT AVE, NORWALK CT 06854
Vivian E. Riefberg	director	800 CONNECTICUT AVENUE, NORWALK CT 06854
Adam Mcananey	officer: General Counsel and Secretary	800 CONNECTICUT AVENUE, NORWALK CT 06854
Marc D Rothman	officer: Chief Medical Officer	800 CONNECTICUT AVENUE, NORWALK CT 06854
Kyle B. Peterson	director	800 CONNECTICUT AVENUE, NORWALK CT 06854
Taj J. Clayton	director	800 CONNECTICUT AVENUE, NORWALK CT 06854
Josh Builder	officer: Chief Technology Officer	800 CONNECTICUT AVENUE, NORWALK CT 06854
Heather Brianne Dixon	director	AETNA INC., 151 FARMINGTON AVENUE, HARTFORD CT 06156
Steve Senneff	officer: Pres. Chief Fin. & Admin. Off.	C/O COTIVITI HOLDINGS, INC., 115 PERIMETER CENTER PLACE, SUITE 700, ATLANTA GA 30346
Bradford Kyle Armbrester	director, officer: Chief Executive Officer	311 ARSENAL STREET, WATERTOWN MA 02472
Albert A Notini	director	C/O DELTEK, INC., 2291 WOOD OAK DRIVE, HERNDON VA 20171
Kevin M Mcnamara	director	2200 DON TYSON PARKWAY, SPRINGDALE AR 72762
Matthew S. Holt	director	C/O NEW MOUNTAIN CAPITAL, LLC, 787 SEVENTH AVENUE, 49TH FLOOR, NEW YORK NY 10019